ELI LILLY & Co (LLY) income statement
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 19/3025% above fair value
$1382.75−32.80 (-2.32%)
Close on Nov 18, 2026Market cap $1.30TP/E 44.9Yield 0.45%
ELI LILLY & Co income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, TTM
- Gross margin
- 83.6%
- Operating margin
- –
- Net margin
- 31.9%
- Return on equity, FY2025
- 101.2%
Financial strength
- Current ratio
- 1.39
- Debt to equity
- 1.23
- Debt to assets
- 33.4%
- Cash to current liabilities
- 10.4%
Valuation
- P/E ratio
- 44.9
- Price to sales
- 15.04
- Price to book
- 32.30
- Dividend yield
- 0.45%
See a number that looks wrong?